Author

Elizabeth Sarles

Observed name: E. Sarles

Institutions: Brigham and Women's Hospital, University of Pittsburgh, Pfizer (United States), Pfizer (United Kingdom), University of Michigan, UCL Queen Square Institute of Neurology, Janssen Alzheimer Immunotherapy Research & Development (United States), University College London

Observed institutions: Brigham and Women's Hospital, University of Pittsburgh, Pfizer (United States), Pfizer (United Kingdom), University of Michigan, University of California San Diego, UCL Queen Square Institute of Neurology, Janssen Alzheimer Immunotherapy Research & Development (United States), University College London

OpenAlex ID: A5111684854

Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

2015 · Enchi Liu, Mark E. Schmidt, et al. · Neurology · 152

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children

2007 · Akihiko Saitoh, Elizabeth Sarles, et al. · AIDS · 111

CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1–Infected Children Receiving Highly Active Antiretroviral Therapy

2010 · Akihiko Saitoh, Edmund Capparelli, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 21

Hemoglobin is a potential risk factor for cognitive dysfunction in adults with sickle cell disease. (P5.031)

2015 · Dana Jorgensen, Enrico Novelli, et al. · Neurology

P4–390: Cognitive correlates of striatal amyloid deposition in preclinical and early autosomal dominant Alzheimer's disease

2013 · Beth Snitz, Eric McDade, et al. · Alzheimer s & Dementia

Works count: 5

Citation count: 284

H-index: 3

I10-index: 3